Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines
Delivery carriers are a critical component in the development of mRNA vaccines. Here, we describe the synthesis of a cationic polymer as a carrier for mRNA cancer vaccine delivery. In vivo results show that this polymer-based mRNA vaccine significantly delays tumor growth after vaccination of mice.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743697/

Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccine-CEJ 2023 Jan
Related Content
OncoWuXi Express will continue to keep you informed of updates to our online pharmacology model database (OncoWuXi Database) and our...
VIEW RESOURCEBuilding on the momentum of AACR 2026, WuXi AppTec was honored to host an outstanding group of regional industry leaders...
VIEW RESOURCE
